We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+14.7%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$26.8B
AUM Growth
+$2.91B
(+12%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
30.26%
Holding
2,338
New
416
Increased
946
Reduced
559
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$80.5M |
| 2 |
Netflix
NFLX
|
+$48M |
| 3 |
Broadcom
AVGO
|
+$47.1M |
| 4 |
Palantir
PLTR
|
+$44.5M |
| 5 |
Intuitive Surgical
ISRG
|
+$41.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$62.2M |
| 2 |
Global Payments
GPN
|
+$50.1M |
| 3 |
Honeywell
HON
|
+$31.1M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$30.5M |
| 5 |
Medtronic
MDT
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.25% |
| 2 | Financials | 14.66% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Communication Services | 9.36% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Xeris Biopharma Holdings
XERS
$1.44B
| $306K | ﹤0.01% |
65,500
+4,600
| +8% | +$21.1K |
|
1502
United Therapeutics
UTHR
$26.3B
| $305K | ﹤0.01% |
+1,062
| New | +$317K |
|
1503
Comstock Resources
CRK
$3.97B
| $304K | ﹤0.01% |
+11,000
| New | +$250K |
|
|
RDUS
1504
DELISTED
Radius Recycling
RDUS
| $303K | ﹤0.01% |
+10,200
| New | +$300K |
|
1505
Entrada Therapeutics
TRDA
$227M
| $302K | ﹤0.01% |
45,000
+3,200
| +8% | +$25.7K |
|
1506
Richardson Electronics
RELL
$261M
| $302K | ﹤0.01% |
31,300
+5,400
| +21% | +$49.2K |
|
1507
Diamondrock Hospitality Co
DRH
$2.63B
| $302K | ﹤0.01% |
39,400
| – | – |
|
1508
Oil States International
OIS
$522M
| $302K | ﹤0.01% |
56,300
+4,600
| +9% | +$20.3K |
|
1509
Archrock
AROC
$6.33B
| $300K | ﹤0.01% |
12,100
-1,000
| -8% | -$24.5K |
|
1510
Republic Bancorp
RBCAA
$1.84B
| $300K | ﹤0.01% |
4,100
+300
| +8% | +$20.5K |
|
1511
Compass Minerals
CMP
$1.24B
| $299K | ﹤0.01% |
+14,900
| New | +$241K |
|
1512
Sensient Technologies
SXT
$5.4B
| $296K | ﹤0.01% |
3,000
+1,400
| +88% | +$125K |
|
1513
Epsilon Energy
EPSN
$176M
| $295K | ﹤0.01% |
+40,000
| New | +$285K |
|
1514
Caledonia Mining Corp
CMCL
$360M
| $294K | ﹤0.01% |
+15,200
| New | +$238K |
|
|
GRAL
1515
GRAIL Inc
GRAL
$2.91B
| $293K | ﹤0.01% |
+5,700
| New | +$206K |
|
1516
Innovative Industrial Properties
IIPR
$1.78B
| $293K | ﹤0.01% |
5,300
| – | – |
|
1517
Cabot Corp
CBT
$4.65B
| $293K | ﹤0.01% |
3,900
-500
| -11% | -$38.3K |
|
1518
Sight Sciences
SGHT
$267M
| $292K | ﹤0.01% |
70,800
+5,000
| +8% | +$16.7K |
|
1519
Neurocrine Biosciences
NBIX
$17.7B
| $291K | ﹤0.01% |
+2,315
| New | +$265K |
|
1520
Sonos
SONO
$1.75B
| $291K | ﹤0.01% |
26,900
+13,100
| +95% | +$127K |
|
|
LTC
1521
LTC Properties
LTC
$2.16B
| $291K | ﹤0.01% |
8,400
| – | – |
|
1522
CNB Financial Corp
CCNE
$1.03B
| $290K | ﹤0.01% |
12,700
+900
| +8% | +$19.8K |
|
1523
Pulse Biosciences
PLSE
$2.09B
| $290K | ﹤0.01% |
19,200
+1,400
| +8% | +$23.2K |
|
1524
Groupon
GRPN
$980M
| $288K | ﹤0.01% |
+8,600
| New | +$219K |
|
1525
Enpro
NPO
$7.05B
| $287K | ﹤0.01% |
1,500
+200
| +15% | +$34.2K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2025 Portfolio in Review
As of Q2 2025, STRS Ohio held 2,338 positions worth $26.8B, up 12% from $23.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
STRS Ohio's Q2 2025 filing shows 416 new, 946 increased, 559 reduced and 143 closed positions. Its largest new stake was Rockwell Automation: 97,205 shares worth $32.3M. The largest sale was Progressive, an estimated $62.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- STRS Ohio's largest Q2 2025 buy was Rockwell Automation: 97,205 shares worth $32.3M.
- STRS Ohio added most to Microsoft in Q2 2025, an estimated $80.5M increase.
- STRS Ohio's biggest Q2 2025 reduction was Progressive, cutting an estimated $62.2M.
- STRS Ohio fully exited AstraZeneca in Q2 2025, selling an estimated $26.8M.
- STRS Ohio's ten largest holdings make up 30% of its $26.8B portfolio in Q2 2025.
- STRS Ohio opened 416 new positions and closed 143 in Q2 2025.
- STRS Ohio's portfolio value rose 12% quarter-over-quarter to $26.8B.
Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.